Quick Answer
AIM ImmunoTech Inc. reported Stockholders Equity of -$9.78 million for fiscal year 2025.
AIM ImmunoTech Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$9.78M | -640.0% |
| 2024 | -$1.32M | -112.9% |
| 2023 | $10.23M | -73.4% |
| 2022 | $38.47M | -32.4% |
| 2021 | $56.88M | -7.2% |
| 2020 | $61.29M | +356.0% |
| 2019 | $13.44M | +0.0% |
| 2019 | $13.44M | +140.9% |
| 2018 | $5.58M | -35.9% |
| 2017 | $8.70M | -43.8% |
| 2016 | $15.50M | -23.9% |
| 2015 | $20.37M | -18.5% |
| 2014 | $25.00M | -14.7% |
| 2013 | $29.30M | -34.5% |
| 2012 | $44.70M | +17.7% |
| 2011 | $37.97M | -17.4% |
| 2010 | $45.95M | -21.7% |
| 2009 | $58.70M | +408.4% |
| 2008 | $11.54M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$6.08M | -308.7% | +7.2% |
| June 30, 2025 | -$6.55M | -207.3% | -69.7% |
| March 31, 2025 | -$3.86M | -179.9% | -191.8% |
| December 31, 2024 | -$1.32M | -112.9% | -122.0% |
| November 30, 2024 | $6.00M | — | +106.0% |
| September 30, 2024 | $2.91M | -87.1% | -52.3% |
| June 30, 2024 | $6.10M | -79.8% | +26.4% |
| March 31, 2024 | $4.83M | -86.2% | -52.8% |
- AIM ImmunoTech Inc. showed a decrease of -640.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, AIM ImmunoTech Inc.’s stockholders equity has declined by 184.7% (from $11.54 million to -$9.78 million).
- The most recent figure is from AIM ImmunoTech Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: